Health and Healthcare

Short Sellers Become More Selective on Major Pharma

The short interest data have been released for the September 30 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study come back negative or a candidate not be approved. Conversely, if a drug is approved or passes a clinical trial, there can be big upside.

The September 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.

Pfizer Inc. (NYSE: PFE) saw its short interest fall to 72.70 million shares from the previous 73.59 million. In February, short interest spiked incredibly, and since that time it has slowly backed off. The highest short interest reading on the year was 207.4 million. Shares of Pfizer closed Friday at $33.24, within a 52-week trading range of $27.51 to $36.46.

Merck & Co. Inc. (NYSE: MRK) saw short interest increase to 40.97 million shares from 40.05 million in the previous period. The current reading is the highest in the past 52 weeks. Merck shares closed Friday at $50.95, in a 52-week trading range of $45.69 to $63.62.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) short interest fell to 7.57 million shares. The previous level was 9.15 million. The highest level in the past 52 weeks was 10.25 million in mid-August. Shares of Teva closed Friday at $58.96, in a 52-week range of $47.36 to $72.31.

Bristol-Myers Squibb Co. (NYSE: BMY) saw its short interest increase to 25.65 million shares from the previous reading of 22.29 million. Bristol-Myers shares closed Friday at $61.44, within a 52-week range of $47.55 to $70.54.

AbbVie Inc. (NYSE: ABBV) short interest increased to 32.17 million shares from the previous level of 31.77 million. Short interest has backed way off its highest level year to date in May; the highest reading in the past 52 weeks was 111.88 million in October 2014. Shares of AbbVie closed Friday at $55.64, in a 52-week trading range of $51.88 to $71.60.

ALSO READ: The 6 Most Shorted NYSE Stocks

The Average American Has No Idea How Much Money You Can Make Today (Sponsor)

The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.

But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.

 

Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

1 https://www.fdic.gov/national-rates-and-rate-caps

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.